JP Morgan Chase’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,162,578
Closed -$45.2M 7375
2022
Q3
$45.2M Buy
2,162,578
+1,769,262
+450% +$36.8M 0.01% 1090
2022
Q2
$8.16M Sell
393,316
-4,552,290
-92% -$81M ﹤0.01% 2338
2022
Q1
$83M Buy
4,945,606
+151,302
+3% +$2.64M 0.01% 927
2021
Q4
$95.7M Buy
4,794,304
+265,732
+6% +$5M 0.01% 912
2021
Q3
$82.1M Sell
4,528,572
-97,690
-2% -$2.24M 0.01% 961
2021
Q2
$125M Buy
4,626,262
+738,040
+19% +$20.6M 0.01% 793
2021
Q1
$117M Buy
3,888,222
+585,304
+18% +$20M 0.02% 777
2020
Q4
$94.9M Buy
3,302,918
+754,020
+30% +$20.4M 0.01% 793
2020
Q3
$62.7M Buy
2,548,898
+2,515,224
+7,469% +$54.2M 0.01% 872
2020
Q2
$603K Buy
33,674
+33,029
+5,121% +$434K ﹤0.01% 3773
2020
Q1
$5K Buy
+645
New +$7.37K ﹤0.01% 5130
2019
Q4
Sell
-1,922,418
Closed -$22.9M 5977
2019
Q3
$22.9M Buy
1,922,418
+1,190,271
+163% +$22M ﹤0.01% 1489
2019
Q2
$17.4M Sell
732,147
-187,443
-20% -$5.4M ﹤0.01% 1671
2019
Q1
$29.3M Buy
+919,590
New +$32.6M 0.01% 1272

Other funds holding CVET

JP Morgan Chase's CVET Position: Q4 2022 in Review

JP Morgan Chase sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 2,162,578 shares — an estimated $45.2M sold.

JP Morgan Chase first reported a position in CVET in Q1 2019 and held it in 14 quarters. The position peaked at $125M in Q2 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • JP Morgan Chase reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 2,162,578 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $45.2M.
  • JP Morgan Chase first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • JP Morgan Chase's Covetrus, Inc. Common Stock position peaked at $125M in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.